Hy2Care

Hy2Care

Hy2Care

Hy2Care develops in situ gelating bioresorbable hydrogels for the arthroscopic treatment of cartilage defects, aiming at functional cartilage repair.
Founded
2014
Raised
$4.2M
Follow us
Alexa global traffic share
Latest funding
€3,700,000
Venture capital (Series A) - 2019
ReumaNederland Brightlands Venture Partners
$16,227
Seed fund - 2015
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Hy2Care makes some noise.